skip to Main Content

Summary

Avalere experts examine the current drug pricing policy landscape and what potential changes stakeholders should prepare for.

The recent proposal by the administration to require manufacturers to disclose list prices in direct-to-consumer (DTC) advertising is the latest in a wave of recent policy activity focused on prescription drugs at the state and federal levels. This includes noteworthy activity such as allowing indication-based formularies in Part D and step therapy in Medicare Advantage, soliciting feedback on new models to manage Part B drugs, and state efforts to manage Medicaid drug costs. So what’s next?

Avalere experts recap recent policy action and preview future policy activity focused on prescription medications. This webinar provides insights into potential changes, market impacts, and considerations for healthcare stakeholders.

Topics covered:

  • Potential action on management of physician-administered drugs
  • Manufacturer rebates
  • State management of drugs in Medicaid
  • Part D reforms

Panelists

Moderator
Elizabeth Carpenter , Senior Vice President, Policy

Elizabeth Carpenter leads the Policy Practice at Avalere.

Speaker
Matt Brow , President

Matt Brow is president of Avalere Health and leads all the firm’s operations, practices, and functions.

Speaker
Miryam Frieder , Vice President, Policy

Miryam Frieder leads strategic client engagements focused on the drug pricing policy environment, rebate reform models, and Medicare Part D. Miryam advises clients on assessing the impact of the evolving policy landscape to inform business decisions and policy engagement strategies.

Speaker
Lance Grady , Vice President, Reimbursement

Lance Grady devises commercialization strategies focused on value, access, and reimbursement.

Speaker
Milena Sullivan , Director, Policy

Milena Sullivan advises life sciences clients on the impact of the evolving healthcare policy landscape on their commercial, access, and advocacy priorities.

From beginning to end, our team synergy
produces measurable results. Let's work together.
Back To Top